TAVR Home Monitoring Pathway
Elevate the standard of care
Elevate and create a new standard of excellence in care with Philips Mobile Cardiac Telemetry - MCOT TAVR Home Monitoring Pathway.
Nearly 1/3 of the transfemoral TAVR
patients who died within
30 days post-procedure were
after hospital discharge1
Benefits
Decrease length-of-stay (LOS) 2
Avoid unnecessary PPM implantations 3
Detect DH-AVB post TAVR
Protect patients from potential post-discharge complications, such as sudden death due to delayed high-grade heart block (DH-AVB), that can occur days to weeks after hospital discharge through the implementation of MCOT.
10%
post-TAVR outpatient MCOT detected high-grade heart block.4
9%
of patients require placement of PPMs post discharge.4
6 days
(Range 3-24 Days)
Median time to develop (DH-AVB) post-procedure.4
Philips ECG Solutions
TAVR Home Monitoring Pathway
Philips TAVR Home Monitoring Pathway enables your organization to meet the 2020 ACC Expert Consensus Guidelines on TAVR which recommends post-TAVR outpatient remote monitoring within 48 hours if the patient is without clear pacemaker indications but is at risk for DH-AVB.
CASE STUDY AND WEBINAR
Northwell Health post-TAVR monitoring experience Comprehensive TAVR monitoring program
Learn how Kabir Bhasin, MD, Electrophysiologist and Director of Clinical Education, Lenox Hill Hospital at Northwell Health was able to leverage MCOT post-TAVR monitoring to reduce unnecessary PPM implantation, decrease LOS by 1.6 days and improve overall patient outcomes.
Kabir Bhasin, MD, FACC
Electrophysiologist Director of Clinical Education, Lenox Hill Hospital Northwell Health® New York, NY
Wayne M. Derkac, MD, FACC
Senior Vice President, Medical Affairs BioTelemetry, Inc., a Philips company Resources